Trial Profile
A Single arm, open label, signal seeking, Phase II a trial of the activity of seviteronel in patients with androgen receptor (AR) positive solid tumours
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 23 Aug 2018
At a glance
- Drugs Dexamethasone (Primary) ; Seviteronel (Primary)
- Indications Solid tumours
- Focus Therapeutic Use
- Acronyms START
- 14 Aug 2018 Status changed from not yet recruiting to recruiting.
- 02 Jul 2018 New trial record